OXCT2P1: A Potential Drug Target and Biomarker (G192217)

Target Name: OXCT2P1

NCBI ID: G192217

OXCT2P1

Other Name(s): OXCT2P | 3-oxoacid CoA-transferase 2 pseudogene 1

OXCT2P1: A Potential Drug Target and Biomarker

OxCT2P1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. OXCT2P1 has been shown to play a role in a variety of physiological processes, including the regulation of inflammation, the development of cancer, and the aging process. As a result, OXCT2P1 has potential as a drug target and biomarker.

The Druggability of OXCT2P1

One of the main reasons for the potential drug targeting of OXCT2P1 is its unique structure and function. OXCT2P1 is a protein that consists of 215 amino acid residues. It has a unique molecular weight of 30.1 kDa and a calculated pI of 12.93. This makes it an ideal target for small molecules, as it has a large surface area and a relatively small size.

In addition, OXCT2P1 has a unique fold structure that allows it to interact with small molecules in a specific way. The protein has a ATP-binding site, which is a common site for proteins that interact with nucleotides. This site is located in the N-terminus of the protein and is responsible for the protein's catalytic activity.

Furthermore, OXCT2P1 has been shown to play a role in various signaling pathways. It has been shown to be involved in the regulation of inflammation, the development of cancer, and the aging process. These functions make OXCT2P1 an attractive drug target, as drugs that target this protein have the potential to treat a variety of diseases.

The Potential Biomarker Property of OXCT2P1

Another reason why OXCT2P1 may be a useful biomarker is its ability to be targeted by small molecules. This allows researchers to test the efficacy of drugs by measuring the levels of OXCT2P1 in cells or tissues. If a drug is able to reduce the levels of OXCT2P1 in cells or tissues, it can be used as a biomarker for that drug.

In addition, OXCT2P1 has been shown to be involved in the regulation of various cellular processes. This makes it an attractive candidate for use as a biomarker for diseases that are related to cellular processes. For example, OXCT2P1 has been shown to be involved in the regulation of cell division, cell migration, and the development of blood vessels.

Conclusion

In conclusion, OXCT2P1 is a protein that has a unique structure and function that makes it an attractive candidate for drug targeting. Its unique molecular weight, pI, and ATP-binding site, as well as its involvement in various signaling pathways and its ability to be targeted by small molecules make it an ideal target for small molecule-based therapeutics. Furthermore, its potential use as a biomarker for diseases related to cellular processes makes it an even more attractive target for drug development.

Protein Name: 3-oxoacid CoA-transferase 2 Pseudogene 1

The "OXCT2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OXCT2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets